Home
Conditions
Liver Neoplasms

Clinical trial condition

Liver Neoplasms

Explore clinical trials studying Liver Neoplasms. Study availability and eligibility vary by location and protocol.

1,782 public trials 491 recruiting studies

Refine in advanced search Browse all conditions

Liver Neoplasms trial results

Recruiting

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

NCT05503797

Conditions: Adenocarcinoma, Adnexal Diseases, Biliary Tract Diseases, +52 more
Locations: Precision NextGen Oncology & Research Center Beverly Hills, California, United States

UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States

University of California Los Angeles Rheumatology Westwood, Los Angeles, California, United States

Norwalk Hospital Norwalk, Connecticut, United States

View all 70 locations

View Trial Details

Recruiting

A Phase IIa, Single-arm, Open-label Clinical Study to Evaluate the Efficacy, Safety and PK of CVM-1118 in Combination With Sintilimab and TACE in Participants With Incurable/Non-metastatic HCC

NCT07521852

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: MengChao Hepatobiliary Hospital of Fujian Medical University Fuzhou, Fujian, China

Zhongshan Hospital, Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Identification of Innovative Biomarkers to Predict Outcomes in Hepatocellular Carcinoma Treated With Tremelimumab and Durvalumab

NCT06796114

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: CHU de Besançon Besançon, France

CH de Chalon sur Saône Chalon-sur-Saône, France

CHU Grenoble Grenoble, France

CH de Mulhouse Mulhouse, France

View Trial Details

Recruiting

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

NCT05208762

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +47 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

University of Alabama at Birmingham, IDS Pharmacy Birmingham, Alabama, United States

University of Alabama at Birmingham Birmingham, Alabama, United States

University of Alabama at Birmingham Birmingham, Alabama, United States

View all 62 locations

View Trial Details

Recruiting

Camrelizumab Combined With Rivoceranib and Hepatic Arterial Infusion Chemotherapy (HAIC) as Conversion Therapy for Potentially Resectable Hepatocellular Carcinoma(HCC)

NCT06796803

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China

Zhongshan Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Outpatient Versus Inpatient Care Pathway for Intra-arterial Treatment of Primary Liver Cancer (CHOC)

NCT06990659

Conditions: Adenocarcinoma, Behavior, Carcinoma, +15 more
Locations: University hospital of Amiens Amiens, France

University hospital of Angers Angers, France

University hospital of Besançon Besançon, France

Hospital of Avicennes (AP-HP) Bobigny, France

View all 19 locations

View Trial Details

Recruiting

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

NCT05092373

Conditions: Adenocarcinoma, Adnexal Diseases, Advanced Breast Carcinoma, +110 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

San Raffaele Registry on Liver Cancer

NCT07704489

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: IRCCS Ospedale San Raffaele Milan, Italy

View Trial Details

Recruiting

To Evaluate Safety and Efficacy of FB-1603 in Hepatocellular Carcinoma Patient Receiving Transarterial Chemoembolization

NCT06478719

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: National Taiwan University Hospital Taipei, Taiwan

Linkou Chang Gung Memorial Hospital Taoyuan, Taiwan

View Trial Details

Recruiting

A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Bevacizumab in Patients With Hepatocellular Carcinoma

NCT07010497

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations: Asan Medical Center, Seoul, South Korea

Seoul National University Hospital Seoul, South Korea

Severance Hospital Seoul, South Korea

View Trial Details

Liver Neoplasms

Liver Neoplasms trial results

Related conditions